Document Detail

Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease.
MedLine Citation:
PMID:  19797828     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: We investigated the significance of urinary liver fatty acid-binding protein (U-L-FABP) monitoring during cardiac catheterization in patients with cardiovascular disease (CVD). Methods The subjects included 27 consecutive patients with stable angina (SAP group) or acute coronary syndrome (ACS group) who had undergone successful percutaneous coronary intervention (PCI), and 12 patients were also enrolled as controls (C group). Urinary and serum parameters were measured immediately before and after and 1 day after PCI. RESULTS: The ratio of U-L-FABP to U-creatinine (U-Cr) (U-L-FABP/U-Cr) in the ACS group was significantly higher than those in both the SAP and C groups before PCI. In addition, none of the patients in the SAP group showed contrast-induced nephropathy (CIN) based on the levels of serum (S)-Cr and U-L-FABP/U-Cr after PCI. Although none of the patients in the ACS group showed CIN according to S-Cr, the level of U-L-FABP/U-Cr was continuously high throughout the study period. Moreover, since there were significant differences in U-L-FABP/U-Cr, U-N-acetyl-beta-D-glucosaminidase, S-uric acid and % medication with calcium channel blockers before PCI between the ACS and SAP groups, a multiple regression analysis was performed using these parameters. It showed that U-L-FABP/U-Cr was most closely associated with the classification of SAP and ACS (p<0.0001). The cut-off level for the greatest sensitivity and specificity for U-L-FABP for the diagnosis of ACS was 13.4 microg/g. Cr in all subjects (sensitivity 0.800, specificity 0.963). CONCLUSIONS: To the best of our knowledge, this is the first report indicating that the measurement of U-L-FABP can be beneficial for in the diagnosis of ACS.
Yusuke Fukuda; Shin-ichiro Miura; Bo Zhang; Atsushi Iwata; Akira Kawamura; Hiroaki Nishikawa; Kazuyuki Shirai; Keijiro Saku
Related Documents :
22258418 - Notes from the field: acute muscular sarcocystosis among returning travelers - tioman i...
15893178 - Elevated levels of ve-cadherin-positive endothelial microparticles in patients with typ...
25232548 - Upper esophageal sphincter abnormalities are strongly predictive of treatment response ...
20155858 - The clinical significance of aspirin resistance in patients with chest pain.
208098 - Cholangiographic abnormalities in patients with inflammatory bowel disease.
24335268 - Assessment of labile plasma iron in patients who undergo hematopoietic stem cell transp...
Publication Detail:
Type:  Journal Article     Date:  2009-10-01
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  48     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2009  
Date Detail:
Created Date:  2009-10-02     Completed Date:  2009-12-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  1731-7     Citation Subset:  IM    
Department of Cardiology, Fukuoka University School of Medicine, Fukuoka.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Coronary Syndrome / diagnosis,  urine
Aged, 80 and over
Angina Pectoris / diagnosis,  urine
Angioplasty, Transluminal, Percutaneous Coronary
Biological Markers / urine
Case-Control Studies
Coronary Artery Disease / diagnosis*,  physiopathology,  therapy,  urine*
Creatinine / urine
Fatty Acid-Binding Proteins / urine*
Glomerular Filtration Rate
Heart Catheterization*
Middle Aged
Sensitivity and Specificity
Reg. No./Substance:
0/Biological Markers; 0/Fatty Acid-Binding Proteins; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stent...
Next Document:  Factors influencing pre-hospital delay after ischemic stroke and transient ischemic attack.